• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ICU MEDICAL, INC. CHEMOLOCK ADDITIVE PORT; CLOSED ANTINEOPLASTIC AND HAZARDOUS DRUG RECONSTITUTION AND TRANSFER SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ICU MEDICAL, INC. CHEMOLOCK ADDITIVE PORT; CLOSED ANTINEOPLASTIC AND HAZARDOUS DRUG RECONSTITUTION AND TRANSFER SYSTEM Back to Search Results
Model Number CL-12
Device Problems Material Fragmentation (1261); Manufacturing, Packaging or Shipping Problem (2975)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 11/18/2021
Event Type  Injury  
Event Description
When bag dry spike with icu medical's chemolock additive port (cl-12) was affixed to bd alaris low sorbing administration set (ref #(b)(4)), there is a potential for coring to occur, this became visible in the drop chamber of the tubing set, and may occur at any time during administration.We witnessed this on the patient towards end of 3 hour infusion.This has happened on two separate occasions with same devices but different medications.We stopped the infusion immediately and do not believe any of the floating 2mm size plastic particulates in the line were infused into the patient.Patient did not have any complaints or other adverse effects from this occurrence.Test completed to ensure aseptic infusion conditions were maintained.Fda safety report id # (b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CHEMOLOCK ADDITIVE PORT
Type of Device
CLOSED ANTINEOPLASTIC AND HAZARDOUS DRUG RECONSTITUTION AND TRANSFER SYSTEM
Manufacturer (Section D)
ICU MEDICAL, INC.
MDR Report Key12924277
MDR Text Key281742665
Report NumberMW5105745
Device Sequence Number1
Product Code ONB
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Voluntary
Reporter Occupation Pharmacist
Type of Report Initial
Report Date 11/30/2021
3 Devices were Involved in the Event: 1   2   3  
1 Patient was Involved in the Event
Date FDA Received12/02/2021
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberCL-12
Device Lot Number5489842
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
BD ALARIS LOW SORBING IV ADMIN SET
Patient Outcome(s) Required Intervention;
Patient Age46 YR
Patient SexFemale
Patient Weight58 KG
Patient EthnicityNon Hispanic
Patient RaceWhite
-
-